A newly released peer-reviewed research paper from the United States reveals that Covid patients who received treatment with Remdesivir were approximately five times more likely to die compared to those treated with either Ivermectin or Hydroxychloroquine.
Nonetheless, the situation could potentially be graver than it seems, as the unprocessed data surprisingly don't take into consideration the decrease in the mortality rate over time, or the disparities in fatalities across diverse age groups.
Despite this, the unadjusted data implies that the prohibition of Ivermectin and Hydroxychloroquine, while promoting Remdesivir, could be seen as an act of severe negligence leading to the loss of thousands of lives.
https://www.ispor.org/docs/default-source/intl2023/ispor23wadeposterrwd26-pdf.pdf
As I believe Mark Twain once said (though he was quoting someone else), "there are lies, damned lies, and statistics".
The stats above mean very little without more information. For example, Remdesivir is recommended by the NIH to treat "high-risk, nonhospitalized patients with mild to moderate COVID-19". One can reasonably assume those were the guidelines used when treating most patients.
For the "unapproved" treatment options, since there are no guidelines, there may well have been many lower risk patients who were treated which would skew the statistics. I don't know this of course but without that kind of demographic info, the stats aren't very meaningful.